A new approach to CTC analysis

Circulating tumour cells can provide valuable information about cancer progression and treatment response. Detecting them reliably, however, remains technically challenging.

OptoSense is developing a compact platform designed to enrich, detect and analyse CTCs from blood samples.

Microfluidic Cell Handling

Microfluidic technology enables controlled processing and sorting of cells within blood samples.

Optical Detection

Autofluorescence signatures can help differentiate CTCs from white blood cells without relying solely on individual biomarkers.

Signal processing and machine-learning approaches are being developed to improve the accuracy and reliability of CTC identification and enumeration.

Intelligent Analysis